SANDS CAPITAL MANAGEMENT, LLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1020066 ARLINGTON, VA

Position in RARE

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$67,344,466

-$12,827,186 QoQ

Shares Held

3,214,533

-7.8% QoQ

Ownership

3.26%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 65.97994172092805.ToString("F0")% Shared 0.ToString("F0")% None 34.020058279071954.ToString("F0")%

Healthcare · as of Mar 31, 2026

SANDS CAPITAL MANAGEMENT, LLC holds $315,837,587 across 2 Biotechnology names. RARE ranks #2 (21.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	ARGX	Argenx SE	340,285	$248,493,121
2	RARE	Ultragenyx Pharmaceutical Inc. This page	3,214,533	$67,344,466

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$67,344,466	3,214,533	-7.8%	Shares	Sole	2026-05-08
2025-12-31	$80,171,652	3,485,724	-7.5%	Shares	Sole	2026-02-13
2025-09-30	$113,397,178	3,769,853	-4.4%	Shares	Sole	2025-11-13
2025-06-30	$143,385,114	3,943,485	-5.3%	Shares	Sole	2025-08-13
2025-03-31	$150,762,543	4,163,561	-3.1%	Shares	Sole	2025-05-14
2024-12-31	$180,816,986	4,298,003	0.0%	Shares	Sole	2025-02-13
2024-12-31	$180,816,986	4,298,003	-16.0%	Shares	Sole	2025-02-12
2024-09-30	$284,319,065	5,118,255	-4.4%	Shares	Sole	2024-11-13
2024-06-30	$220,080,225	5,354,750	+38.7%	Shares	Sole	2024-08-13
2024-03-31	$180,197,580	3,859,447	-6.3%	Shares	Sole	2024-05-14
2023-12-31	$196,923,142	4,118,008	+59.8%	Shares	Sole	2024-02-13
2023-09-30	$91,877,786	2,577,217	-3.6%	Shares	Sole	2023-11-14
2023-06-30	$123,334,920	2,673,638	—	Shares	Sole	2023-08-15
No filing history on record for this holder in this stock.